Women with PMOS Should Get Annual Review, Says NICE
The National Institute for Health and Care Excellence (NICE) has issued new guidelines recommending annual reviews for women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as PCOS. The name change and updated guidance aim to improve diagnosis and management of the condition's broad metabolic and reproductive health impacts.
Why it matters
Standardizing care for this common condition could significantly improve long-term health outcomes and reduce diagnostic delays for millions of women.
WOMEN with polyendocrine metabolic ovarian syndrome (PMOS) should be offered an annual review to monitor their symptoms, treatment, and long-term health risks, according to a new draft guideline from the National Institute for Health and Care Excellence (NICE).
The article summarizes medical guidelines and public health recommendations objectively.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in